Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
about
How safe and effective is denosumab for bone giant cell tumour?TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.Denosumab-Treated Giant Cell Tumor of the Bone Mimicking Low-Grade Central Osteosarcoma.Expression of MMP-2 and TIMP-3 with incidence and prognosis of giant-cell tumor of the bone.
P2860
Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Clinicopathological Features o ...... Cancer Referral Centre, India.
@en
Clinicopathological Features o ...... Cancer Referral Centre, India.
@nl
type
label
Clinicopathological Features o ...... Cancer Referral Centre, India.
@en
Clinicopathological Features o ...... Cancer Referral Centre, India.
@nl
prefLabel
Clinicopathological Features o ...... Cancer Referral Centre, India.
@en
Clinicopathological Features o ...... Cancer Referral Centre, India.
@nl
P2093
P2860
P1476
Clinicopathological Features o ...... Cancer Referral Centre, India.
@en
P2093
Ashish Gulia
Bharat Rekhi
Jyoti Bajpai
Nirmala A Jambhekar
Shashikant L Juvekar
Subhash Desai
Vivek Verma
P2860
P2888
P304
P356
10.1007/S12253-016-0123-0
P577
2016-10-08T00:00:00Z